已收盘 09-20 16:00:00 美东时间
+0.110
+3.49%
Lexaria Bioscience (NASDAQ:LEXX) on Thursday said Chief Executive Officer Chris Bunka is stepping aside for the appointment of Richard Christopher as new CEO, effective August 31, 2024. Most recently,...
09-05 22:49
Gainers Theriva Biologics (AMEX:TOVX) shares moved upwards by 25.0% to $5.88 d...
09-03 00:30
Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience has announ...
08-28 00:37
Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience reports pr...
08-22 01:37
Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience Corp. anno...
08-20 00:09
HC Wainwright & Co. analyst Yi Chen reiterates Lexaria Bioscience (NASDAQ:LEXX) with a Buy and maintains $10 price target.
07-19 00:40
Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience reports pr...
07-18 01:40
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.10) by 30 percent. This is a 64.86 percent increase over losses of $(0.37) per share from
07-13 02:07
Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience Corp. has ...
07-10 01:08